NCT06140888
Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke
Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke: a Multicentre, Randomised, Open-label, Blinded-Endpoint Trial
Yi Yang·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Acute Ischemic Stroke
- Drug/Device/Intervention
- Ginkgo Biloba Extract
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Yi Yang
- Funder
- The First Hospital of Jilin University
Timeline & enrollment
- Phase
- N/A
- Start date
- Jan 01, 2024
- End date
- Apr 01, 2027
- Enrollment
- 356 participants
Primary outcome
Changes of the Montreal Cognitive Assessment (MoCA) score
Summary
The purpose of this study is to determine the effect of ginkgo biloba extract on cognitive
 function in acute ischemic stroke.
ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionCerebral infarction, unspecifiedTransient cerebral ischaemic attack, unspecified
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06140888
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06140888 through Pure Global AI's free database. This phase not specified trial is sponsored by Yi Yang and is currently Not yet recruiting. The study focuses on Acute Ischemic Stroke. Target enrollment is 356 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.